LICOCHALCONEC

Research use only, not for human use.

Licochalcone C has potent antioxidant properties and inhibition of bacterial growth and cellular respiration.

Licochalcone C is an inhibitor of lipopolysaccharide-interferon-γ inflammation. It acts by improving antioxidant conditions and regulating inducible nitric oxide synthase expression. It acts as an inhibitor of recombinant human PTP1B assessed as hydrolysis of p-nitrophenyl phosphate.

Licochalcone C could inhibit α- glucosidase, with IC50s of <100 nM and 92.43 μM for α- glucosidase and PTP1B, respectively. It is also indicated that Licochalcone C induces T24 cell apoptosis in a concentration?dependent manner. Licochalcone C treatment reduces the levels of the anti?apoptotic mRNAs (Bcl-2, Bcl-w and Bcl-XL) and increases expression of the pro-apoptotic mRNAs (Bax and Bim). The Bcl-2 family inhibitor (ABT-737) reduces apoptosis induced by licochalcone C in T24 cells.

——

Licochalcone C | Licochalcone-C

Others

Other Targets

Antioxidant

——

——

144506-14-9

338.39

C21H22O4

>98% (HPLC)

In Vitro:?DMSO : 33.33 mg/mL (98.49 mM)

COc1c(\C=C\C(=O)c2ccc(O)cc2)ccc(O)c1CC=C(C)C

(E)-3-[4-Hydroxy-2-methoxy-3-(3-methylbut-2-enyl)phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one

(-20℃)

With Ice Pack

≥ 2 years